Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micronized progesterone as adjunctive treatment in refractory status epilepticus (Phase IIa)
TCTR20200717002Phase 2Completed
- Sponsor
- Phramongkutklao Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of progesterone in status epilepticus (SE), sponsored by Phramongkutklao Hospital. Started Jan 2019; status: completed.
02
Drugs
progesterone
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on TCTR20200717002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200717002.